Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on strong efficacy shown in previous studies, the drugmaker said on Thursday.

All patients in the trial will have the opportunity to resume or begin treatment with Winrevair, the company said.

The Nigerian-American Chamber of Commerce is set to hold a summit to shape the future of business relations between Nigeria and the United States in 2025. The NACC in a statement said the event ...

STMicroelectronics (NYSE:STM)(EPA:STMPA) on Thursday warned of an even weaker first quarter in 2025, signaling continued challenges in the semiconductor market as the industry struggles with soft ...

This year, one of the best watches unveiled at the show was a new Zenith Chronomaster Sport model. That was one of a pair of ...

A Federal High Court on Wednesday set aside its Mareva orders that froze $225.8 million in assets and accounts linked ...

In today's episode of Fratello Talks, the guys discuss this year's LVMH Watch Week ✓ Tune in to hear about all the new releases! ✓ ...

The other injunctive orders, namely orders 6,7,8,9,10 and 11 were not discharged or set aside, and remain valid and subsisting, the counsel said.

The Adam Watson-led APA is understood to be instead focusing – at this time – on organic opportunities within its existing ...

Over two days of schmoozing with executives employed by one of the most powerful groups in the industry, here are the ...

Jim Jarmusch, the celebrated American director behind several cinematic gems, is also a lover of rock and a passionate ...